NEPHROS, INC. Net Income (Loss) Available to Common Stockholders, Diluted
NEPHROS, INC. (NEPH) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$835.00 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2016-08-08
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2016-06-30 was -$835.00K.
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2016-03-31 was -$836.00K.
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2015-09-30 was -$581.00K.
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2015-06-30 was -$619.00K.
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for fiscal 2013 was -$3.70M.
- NEPHROS, INC. net income (loss) available to common stockholders, diluted for fiscal 2010 was $3.88M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | -$835.00K 10-Q · filed 2016-08-08 | -$1.67M 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | -$836.00K 10-Q · filed 2016-05-11 | ||||
| 2015-09-30 | -$581.00K 10-Q · filed 2015-11-10 | -$1.20M derived: sum of 2 quarters · filed 2016-08-08 | -$2.15M 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | -$619.00K 10-Q · filed 2016-08-08 | -$1.38M 10-Q · filed 2016-08-08 | |||
| 2015-03-31 | -$766.00K 10-Q · filed 2016-05-11 | ||||
| 2014-09-30 | -$705.00K 10-Q · filed 2015-11-10 | -$706.00K 10-K · filed 2015-04-15 | -$1.36M derived: sum of 2 quarters · filed 2015-11-10 | -$6.13M 10-Q · filed 2015-11-10 | |
| 2014-06-30 | -$654.00K 10-Q · filed 2015-08-10 | -$1.41M 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | -$760.00K 10-Q · filed 2015-05-15 | ||||
| 2013-12-31 | -$3.70M 10-K · filed 2015-04-15 | ||||
| 2013-06-30 | -$670.00K derived: 10-K 6 month − 10-K 3 month · filed 2015-04-15 | -$1.91M 10-K · filed 2015-04-15 | |||
| 2013-03-31 | -$1.24M 10-K · filed 2015-04-15 | ||||
| 2010-12-31 | $3.88M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |